Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
2,878
-186
-6% -$63.7K 0.15% 138
2026
Q1
$1.08M Sell
3,064
-83
-3% -$29.6K 0.17% 119
2025
Q4
$1.03M Sell
3,147
-5
-0.2% -$1.59K 0.16% 114
2025
Q3
$889K Sell
3,152
-4,824
-60% -$1.4M 0.12% 149
2025
Q2
$2.23M Buy
7,976
+479
+6% +$136K 0.31% 73
2025
Q1
$2.34M Sell
7,497
-161
-2% -$47.5K 0.41% 61
2024
Q4
$2M Buy
7,658
+8
+0.1% +$2.37K 0.35% 72
2024
Q3
$2.46M Sell
7,650
-117
-2% -$38.3K 0.43% 59
2024
Q2
$2.43M Sell
7,767
-720
-8% -$212K 0.49% 49
2024
Q1
$2.41M Buy
8,487
+513
+6% +$150K 0.5% 50
2023
Q4
$2.3M Sell
7,974
-116
-1% -$31.6K 0.51% 50
2023
Q3
$2.17M Buy
8,090
+215
+3% +$53.7K 0.55% 49
2023
Q2
$1.75M Buy
7,875
+216
+3% +$50.1K 0.42% 62
2023
Q1
$1.85M Sell
7,659
-1,139
-13% -$280K 0.46% 52
2022
Q4
$2.31M Buy
8,798
+482
+6% +$129K 0.58% 46
2022
Q3
$1.88M Sell
8,316
-202
-2% -$49K 0.49% 53
2022
Q2
$2.07M Buy
8,518
+620
+8% +$152K 0.52% 53
2022
Q1
$1.91M Sell
7,898
-199
-2% -$45.7K 0.41% 65
2021
Q4
$1.82M Sell
8,097
-80
-1% -$16.9K 0.36% 80
2021
Q3
$1.74M Sell
8,177
-635
-7% -$146K 0.38% 75
2021
Q2
$2.15M Buy
8,812
+5,603
+175% +$1.38M 0.51% 53
2021
Q1
$798K Sell
3,209
-413
-11% -$98.5K 0.27% 100
2020
Q4
$833K Buy
3,622
+199
+6% +$45.9K 0.29% 96
2020
Q3
$870K Buy
3,423
+49
+1% +$12.1K 0.36% 83
2020
Q2
$796K Buy
3,374
+100
+3% +$22.8K 0.35% 81
2020
Q1
$664K Sell
3,274
-70
-2% -$15.3K 0.34% 82
2019
Q4
$807K Sell
3,344
-155
-4% -$34.2K 0.33% 82
2019
Q3
$677K Sell
3,499
-217
-6% -$41.7K 0.29% 94
2019
Q2
$685 Buy
3,716
+100
+3% +$17.9K 0.29% 95
2019
Q1
$687 Sell
3,616
-100
-3% -$19.1K 0.3% 90
2018
Q4
$723 Hold
3,716
0.34% 77
2018
Q3
$771K Sell
3,716
-75
-2% -$14.8K 0.31% 84
2018
Q2
$700K Sell
3,791
-1,487
-28% -$263K 0.3% 85
2018
Q1
$900K Sell
5,278
-8,581
-62% -$1.58M 0.38% 69
2017
Q4
$2.41M Sell
13,859
-189
-1% -$33.4K 0.96% 42
2017
Q3
$2.62K Sell
14,048
-2,633
-16% -$467K 1.1% 32
2017
Q2
$2.87K Sell
16,681
-141
-0.8% -$22.9K 1.28% 27
2017
Q1
$2.76K Sell
16,822
-1,683
-9% -$280K 1.22% 25
2016
Q4
$2.71M Buy
18,505
+2,167
+13% +$326K 1.17% 23
2016
Q3
$2.73M Sell
16,338
-279
-2% -$47.2K 1.19% 26
2016
Q2
$2.53M Sell
16,617
-285
-2% -$44.3K 1.04% 30
2016
Q1
$2.53M Buy
16,902
+590
+4% +$87.7K 1.05% 29
2015
Q4
$2.65M Buy
16,312
+3,465
+27% +$545K 1.03% 26
2015
Q3
$1.78M Buy
12,847
+4,714
+58% +$743K 0.68% 49
2015
Q2
$1.25M Buy
8,133
+1,064
+15% +$170K 0.44% 71
2015
Q1
$1.13M Buy
+7,069
New +$1.11M 0.39% 80

Other funds holding AMGN

Chicago Trust's AMGN Position: Q2 2026 in Review

Chicago Trust reduced its Amgen (AMGN) stake by 6.1% in Q2 2026, selling an estimated $63.7K and leaving 2,878 shares worth $1.04M. The position accounts for 0.15% of the portfolio, ranked #138.

Chicago Trust first reported a position in AMGN in Q1 2015 and has held it in 46 quarters since. The position peaked at $2.73M in Q3 2016. 687 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Chicago Trust held 2,878 shares of Amgen worth $1.04M as of Q2 2026.
  • Chicago Trust sold 186 Amgen shares in Q2 2026, an estimated $63.7K.
  • Amgen made up 0.15% of Chicago Trust's portfolio in Q2 2026, its #138 holding.
  • Chicago Trust first reported a position in Amgen in Q1 2015 and has held it in 46 quarters since.
  • Chicago Trust's Amgen position peaked at $2.73M in Q3 2016.
  • 687 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.